Latest Bavarian Nordic Stories
Bavarian Nordic, an industrial biotechnology company, has completed a clinical safety report from a large Phase II study with Imvamune in HIV infected subjects that confirms the excellent safety profile of Imvamune.
Bavarian Nordic, an industrial biotechnology company, has evaluated the mature Phase II data from the therapeutic prostate cancer vaccine candidate Prostvac that had been obtained as part of the recently entered partnership with the National Cancer Institute in the US.
Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics, has entered into a scientific partnership with the National Cancer Institute in the US. Under the co-operative R&D agreement, both the entities will jointly develop new immunotherapies for the treatment of prostate cancer.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.